Category: 64-10-8

Hsiao, YJ; Lin, LY in [Hsiao, Yu-Jui; Lin, Lu-Yin] Natl Taipei Univ Technol, Dept Chem Engn & Biotechnol, Taipei 10608, Taiwan; [Lin, Lu-Yin] Res Ctr Energy Conservat New Generat Residential, Taipei 10608, Taiwan published Enhanced Surface Area, Graphene Quantum Dots, and Functional Groups for the Simple Acid-Treated Carbon Fiber Electrode of Flexible Fiber-Type Solid-State Supercapacitors without Active Materials in 2020.0, Cited 35.0. Name: 1-Phenylurea. The Name is 1-Phenylurea. Through research, I have a further understanding and discovery of 64-10-8.

Flexible fiber-type solid-state supercapacitors (FSCs) are demanded for energy storage of wearable soft electronics. A flexible carbon fiber (CF) with high electrical conductivity and good energy storage ability can act as the current collector and the active material simultaneously. Improving the energy storage ability of the CF without depositing active materials is highly promising to avoid active materials from peeling off, especially under bending conditions. In this study, the CF is treated with acid mixtures containing different HNO3 to H2SO4 ratios. The roughened surface and the production of graphene quantum dots and functional groups are achieved for the acid-treated CF, especially for the CF treated with the acid mixtures. The largely enhanced specific capacitance (C-L) is first obtained for the optimized CF electrode (641.08 mF/cm at 5 mV/s) treated with the acid mixture containing the HNO3 to H2SO4 ratio of 1 to 3. The FSC also shows a maximum energy density of 16.57 mu W h/cm at the power density of 62.50 mu W/cm, as well as a C-L retention of 77% and Coulombic efficiency of 100% in 5000 times of a charge/discharge cycling process. Excellent flexibility is also attained for the FSC with no shape distortion of cyclic voltammetry curves measured under the bending angle of 180 degrees and with 1000 times of repeated bending. This work proposes a simple acid treatment to largely enhance the energy storage ability of pure CF electrodes. The bifunctional substance with current collecting and energy storing abilities is expected to be well developed in the future for applying on numerous efficient flexible energy storage devices.

About 1-Phenylurea, If you have any questions, you can contact Hsiao, YJ; Lin, LY or concate me.. Name: 1-Phenylurea

Reference:
Thiomorpholine – Wikipedia,
,Thiomorpholine | C4H9NS – PubChem

An article Electrochemical behavior study of some selected phenylurea herbicides at activated pencil graphite electrode. Electrooxidation of linuron and monolinuron WOS:000468714400137 published article about PERFORMANCE LIQUID-CHROMATOGRAPHY; VOLTAMMETRIC DETERMINATION; GAS-CHROMATOGRAPHY; CARBON; SAMPLES; WATER; SOIL; ADSORPTION; EXTRACTION; PESTICIDES in [Buleandra, Mihaela; Popa, Dana Elena; David, Iulia Gabriela; Bacalum, Elena; David, Victor; Ciucu, Anton Alexandru] Univ Bucharest, Dept Analyt Chem, Fac Chem, 90-92 Panduri Av, Bucharest 050663, Romania in 2019.0, Cited 45.0. The Name is 1-Phenylurea. Through research, I have a further understanding and discovery of 64-10-8. Name: 1-Phenylurea

A novel and rapid voltammetric assay for the simultaneous determination of monolinuron (MLN) and linuron (LIN) using an electrochemically pretreated pencil graphite electrode (PGE*) is reported for the first time. Enhanced oxidation peak currents of MLN and LIN were observed at PGE* when compared with electrochemically non-pretreated PGE. Differential pulse voltammetric (DPV) results showed distinct anodic peaks at 1.064 V and 1.170 V for MLN and LIN, respectively. Under optimum conditions, the detection limits were 3.7 x 10(-7) mol L-1 and 5.8 x 10(-7) mol L-1 for MLN and LIN respectively. The DPV method was applied for the quantitative determination of the mentioned compounds in spiked tap water samples enriched by solid phase extraction. The voltammetric results were in good agreement with high-performance liquid chromatography data.

Name: 1-Phenylurea. About 1-Phenylurea, If you have any questions, you can contact Buleandra, M; Popa, DE; David, IG; Bacalum, E; David, V; Ciucu, AA or concate me.

Reference:
Thiomorpholine – Wikipedia,
,Thiomorpholine | C4H9NS – PubChem

Authors Viti, ML; Mendes, KF; dos Reis, FC; Guimaraes, ACD; Soria, MTM; Tornisielo, VL in SPRINGER INDIA published article about DEGRADATION; DIURON; HEXAZINONE; PESTICIDES; DISSIPATION; METRIBUZIN; FATE; VINASSE; CANE in [Viti, Marcela Lembi; dos Reis, Fabricia Cristina; Tornisielo, Valdemar Luiz] Univ Sao Paulo, Ctr Nucl Energy Agr, Piracicaba, SP, Brazil; [Mendes, Kassio Ferreira] Univ Fed Vicosa, Vicosa, MG, Brazil; [Dias Guimaraes, Ana Carolina] Univ Mato Grosso State, Alta Floresta, Mato Grosso, Brazil; [Martinez Soria, Maria Teresa] Univ La Rioja, Logrono, La Rioja, Spain in 2021.0, Cited 47.0. Recommanded Product: 1-Phenylurea. The Name is 1-Phenylurea. Through research, I have a further understanding and discovery of 64-10-8

This study evaluated the remobilization, mineralization, and metabolism of herbicide-bound residues in soils amended with various types of sugarcane waste. Soil with bound residues of three herbicides and fresh soil samples were added to the biometric flasks, followed by the addition of vinasse, filter cake, or sugarcane straw in order to reactivate the microbial activity. In sandy loam soil, higher mineralization was observed where filter cake was added, and the maximum mineralized percentage was 7.7, 46.7, and 8.1% of diuron-, hexazinone-, and metribuzin-bound residues, respectively. Conversely, this soil presented a greater percentage of re-extractable hexazinone and metribuzin residues when vinasse was added. Among the examined herbicides, a higher percentage of bound metribuzin residues remained in the soil (57.5-75.6%). It was possible to identify both metabolites and parent compounds in the re-extracted residues, implying either species could bind to the soil. Therefore, this study has shown that bound residues of three herbicides and their metabolites can become bioavailable, and mineralized or returned to the soil solution, which could adversely affect subsequent crops or non-target organisms. Hence, the remobilization of bound residues must be taken into account when assessing the environmental risk of herbicides in soils in registration processes.

Recommanded Product: 1-Phenylurea. About 1-Phenylurea, If you have any questions, you can contact Viti, ML; Mendes, KF; dos Reis, FC; Guimaraes, ACD; Soria, MTM; Tornisielo, VL or concate me.

Reference:
Thiomorpholine – Wikipedia,
,Thiomorpholine | C4H9NS – PubChem

In 2019.0 LUNG CANCER published article about NSCLC; CHEMOTHERAPY; DOCETAXEL; SYSTEM in [Crino, Lucio; Bronte, Giuseppe; Cravero, Paola; Delmonte, Angelo] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Meldola, Italy; [Bidoli, Paolo] Osped San Gerardo, Monza, Italy; [Minenza, Elisa] AO Santa Maria, Terni, Italy; [Cortesi, Enrico] Policlin Umberto 1, Rome, Italy; [Garassino, Marina C.; Proto, Claudia] Fdn IRCCS Ist Nazl Tumori, Milan, Italy; [Cappuzzo, Federico] AUSL Romagna, Ravenna, Italy; [Grossi, Francesco] IRCCS AOU San Martino IST, Genoa, Italy; [Tonini, Giuseppe] Policlin Univ Campus Biomed, Rome, Italy; [Sarobba, Maria Giuseppina] ASL 3 S Francesco, Nuoro, Italy; [Pinotti, Graziella] Osped Circolo & Fdn Macchi, Varese, Italy; [Numico, Gianmauro] AO SS Antonio & Biagio & C Arrigo, Alessandria, Italy; [Samaritani, Riccardo] Presidio Nuovo Regina Margherita, Rome, Italy; [Ciuffreda, Libero] AOU Citta Salute & Sci Torino, Turin, Italy; [Frassoldati, Antonio] Arcispedale S Anna Ferrara, Ferrara, Italy; [Bregni, Marco] Presidio Osped Busto Arsizio, Varese, Italy; [Santo, Antonio] AO Univ Integrata Verona, Verona, Italy; [Piantedosi, Francovito; Illiano, Alfonso] AO Colli, Monaldi Cotugno CTO, Naples, Italy; [De Marinis, Filippo] European Inst Oncol, Milan, Italy; [Tamberi, Stefano] Infermi Hosp, Faenza, Italy; [Giannarelli, Diana] Regina Elena Natl Canc Inst IRCCS, Rome, Italy in 2019.0, Cited 22.0. The Name is 1-Phenylurea. Through research, I have a further understanding and discovery of 64-10-8. HPLC of Formula: C7H8N2O

Objectives: Brain metastases are common among patients with non-squamous non-small-cell lung cancer (NSCLC) and result in a poor prognosis. Consequently, such patients are often excluded from clinical trials. In Italy an expanded access program (EAP) was used to evaluate nivolumab efficacy and safety in this sub population outside a clinical trial. Materials and methods: In this EAP, nivolumab was available for patients with non-squamous NSCLC in progression after at least one systemic treatment for stage IIIB/IV disease. Nivolumab 3 mg/kg was administered intravenously every 2 weeks. Patients with brain metastases could be included if they were asymptomatic, neurologically stable and either off corticosteroids or on a stable or decreasing dose of <= 10 mg/day prednisone. Results: 409 out of 1588 patients included had asymptomatic or controlled brain metastases. A median of 7 doses (range 1-45) were delivered. Median follow-up was 6.1 months (range 0.1-21.9). The disease control rate was 39%: 4 patients had a complete response, 64 a partial response and 96 showed stable disease. At baseline, 118 patients were on corticosteroids and 74 were undergoing concomitant radiotherapy. The median overall survival in this subpopulation was 8.6 months (95% CI: 6.4-10.8). 337 discontinued treatment for various reasons, 23 (7%) of whom due to adverse events, in line with that observed in the overall population and in previous studies. Conclusions: Our results confirm that nivolumab is active in non-squamous NSCLC patients with brain metastases, despite their poor prognosis. Its safety profile is also concordant with results in the EAP overall population and in patients with other malignancies. HPLC of Formula: C7H8N2O. About 1-Phenylurea, If you have any questions, you can contact Crino, L; Bronte, G; Bidoli, P; Cravero, P; Minenza, E; Cortesi, E; Garassino, MC; Proto, C; Cappuzzo, F; Grossi, F; Tonini, G; Sarobba, MG; Pinotti, G; Numico, G; Samaritani, R; Ciuffreda, L; Frassoldati, A; Bregni, M; Santo, A; Piantedosi, F; Illiano, A; De Marinis, F; Tamberi, S; Giannarelli, D; Delmonte, A or concate me.

Reference:
Thiomorpholine – Wikipedia,
,Thiomorpholine | C4H9NS – PubChem

In 2020.0 J SERB CHEM SOC published article about DENSITY-FUNCTIONAL THERMOCHEMISTRY; ONE-POT SYNTHESIS; MILD-STEEL; ACID; DFT in [Akbas, Esvet; Yildiz, Ela; Erdogan, Ahmet] Van Yuzuncu Yil Univ, Dept Chem, TR-65080 Van, Turkey in 2020.0, Cited 21.0. The Name is 1-Phenylurea. Through research, I have a further understanding and discovery of 64-10-8. HPLC of Formula: C7H8N2O

In this study, five new pyrimidine derivatives were synthesized and characterized by characterization methods such as H-1-NMR, C-13-NMR, FT-IR and elemental analysis. The corrosion inhibition activity of the synthesized compounds was examined by theoretical calculation using DFT method at the level of B3LYP/6-31G (d,p). According to the calculations, 4-(6-benzoyl-2-benzylidene-3-oxo-7-phenyl-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidin-5-yl)-benzoic acid (6) appears to be a good inhibitor for corrosion.

HPLC of Formula: C7H8N2O. About 1-Phenylurea, If you have any questions, you can contact Akbas, E; Yildiz, E; Erdogan, A or concate me.

Reference:
Thiomorpholine – Wikipedia,
,Thiomorpholine | C4H9NS – PubChem

Safety of 1-Phenylurea. In 2020.0 J HETEROCYCLIC CHEM published article about CRYSTAL-STRUCTURE; MODULAR APPROACH; DERIVATIVES; CUCURBITURIL in [Bakibaev, Abdigali A.; Uhov, Artur; Malkov, Victor S.; Panshina, Svetlana Yu.] Natl Res Tomsk State Univ, Dept Chem, Tomsk 634050, Russia; [Panshina, Svetlana Yu.] Natl Res Tomsk Polytech Univ, Dept Chem, Tomsk, Russia in 2020.0, Cited 52.0. The Name is 1-Phenylurea. Through research, I have a further understanding and discovery of 64-10-8.

Most of the known methods for the synthesis of heterocyclic compounds have disadvantages, such as a long reaction time and aggressive conditions. We have developed a new, rather simple and efficient method for the synthesis of a number of glycoluryls and hydantoins in water using a etidronic acid (HEDP) as Green catalyst. So, for the first time, the condensation reaction of ureas with 1, 2-dicarbonyl compounds was carried out in the presence of HEDP. Also based on NMR studies, a chemism of these reactions, which is stepwise, is proposed. It has been established that the optimal conditions for the synthesis of glycoluryls and hydantoins using HEDP are: temperature 80 degrees C-90 degrees C, 40-20 minutes, and the ratio of urea and HEDP is 1:1. In all cases, the remaining aqueous filtrate containing HEDP after the reaction can be reused for other cycles synthesis of glycoluril and other compounds, because HEDP is not converted during the reaction.

Safety of 1-Phenylurea. About 1-Phenylurea, If you have any questions, you can contact Bakibaev, AA; Uhov, A; Malkov, VS; Panshina, SY or concate me.

Reference:
Thiomorpholine – Wikipedia,
,Thiomorpholine | C4H9NS – PubChem

Safety of 1-Phenylurea. Jabbour, SA; Frias, JP; Ahmed, A; Hardy, E; Choi, J; Sjostrom, CD; Guja, C in [Jabbour, Serge A.] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Frias, Juan P.] Natl Res Inst, Los Angeles, CA USA; [Ahmed, Azazuddin] Apex Med Res, Chicago, IL USA; [Hardy, Elise] AstraZeneca, Gaithersburg, MD USA; [Choi, Jasmine] Statum Res, Irvine, CA USA; [Sjostrom, C. David] AstraZeneca, Gothenburg, Sweden; [Guja, Cristian] Carol Davila Univ Med & Pharm, Bucharest, Romania published Efficacy and Safety Over 2 Years of Exenatide Plus Dapagliflozin in the DURATION-8 Study: A Multicenter, Double-Blind, Phase 3, Randomized Controlled Trial in 2020.0, Cited 17.0. The Name is 1-Phenylurea. Through research, I have a further understanding and discovery of 64-10-8.

OBJECTIVE In patients with type 2 diabetes uncontrolled with metformin, exenatide once weekly (QW) plus dapagliflozin produced greater reductions in glycemic parameters (glycated hemoglobin [HbA(1c)], fasting plasma glucose [FPG], and 2-h postprandial glucose [2-h PPG]), weight, and systolic blood pressure (SBP) than exenatide QW or dapagliflozin alone after 28 weeks of treatment in DURATION-8. Following a 24-week extension period, improvements were sustained at 52 weeks. In this study, we investigated efficacy and safety at 104 weeks after randomization. RESEARCH DESIGN AND METHODS DURATION-8 was a 104-week, multicenter, double-blind, randomized, active-controlled, phase 3 trial. In total, 695 adults (aged >= 18 years) with type 2 diabetes and inadequate glycemic control (HbA(1c)8.0-12.0% [64-108 mmol/mol]) despite stable metformin monotherapy (>= 1,500 mg/day) were randomly assigned (1:1:1) to receive exenatide 2 mg QW plus once-daily dapagliflozin 10 mg, exenatide QW plus placebo, or dapagliflozin plus placebo. All 104-week evaluations were exploratory. RESULTS At week 104, 431 (62.0%) patients completed treatment. The adjusted least squares mean change (SE) from baseline to week 104 in HbA(1c)was greater with exenatide QW plus dapagliflozin (-1.70% [0.11]) versus exenatide QW plus placebo (-1.29% [0.12];P= 0.007) and dapagliflozin plus placebo (-1.06% [0.12];P< 0.001). Clinically relevant changes in FPG, 2-h PPG, weight, and SBP were also observed with exenatide QW plus dapagliflozin. There were no unexpected safety findings, and exenatide QW plus dapagliflozin was well tolerated, with no episodes of major hypoglycemia. CONCLUSIONS In this exploratory analysis, among those individuals who completed the trial without rescue therapy, there was clinically relevant efficacy over 2 years with exenatide QW plus dapagliflozin, with no unexpected safety findings. Safety of 1-Phenylurea. About 1-Phenylurea, If you have any questions, you can contact Jabbour, SA; Frias, JP; Ahmed, A; Hardy, E; Choi, J; Sjostrom, CD; Guja, C or concate me.

Reference:
Thiomorpholine – Wikipedia,
,Thiomorpholine | C4H9NS – PubChem

An article Dual Kit/Aur Inhibitors as Chemosensitizing Agents for the Treatment of Melanoma: Design, Synthesis, Docking Studies and Functional Investigation WOS:000474505900054 published article about AURORA KINASE; MEK INHIBITION; DRUG DESIGN; MECHANISMS; RESISTANCE; BRAF; KIT; IDENTIFICATION; VEMURAFENIB; SIMULATION in [Quattrini, Luca; Coviello, Vito; Sartini, Stefania; La Motta, Concettina] Univ Pisa, Dipartimento Farm, Via Bonanno 6, I-56126 Pisa, Italy; [Di Desidero, Teresa; Orlandi, Paola; Bocci, Guido] Univ Pisa, Dipartimento Med Clin & Sperimentale, Via Roma 55, I-56126 Pisa, Italy; [Ke, Yi-Yu; Liu, Kai-Lun; Hsieh, Hsing-Pang] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, 35 Keyan Rd, Zhunan Town 350, Miaoli County, Taiwan in 2019.0, Cited 46.0. Product Details of 64-10-8. The Name is 1-Phenylurea. Through research, I have a further understanding and discovery of 64-10-8

Melanoma is the most serious form of skin cancer but its medication is still far from being safe and thoroughly effective. The search of novel therapeutic approaches represents therefore a health emergency to push through eagerly. In this study, we describe a novel class of dual c-Kit/Aur inhibitors, characterized by a 1,2,4-triazole core and developed by a structure-based optimization of a previously developed hit, and report the evidence of their significance as drug candidates for the treatment of melanoma. Compound 6a, merging the best inhibitory profile against the target kinases, showed anti-proliferative efficacy against the human melanoma cell lines A2058, expressing the BRAFV600D mutation, and WM266-4, expressing BRAF V600E. Significantly, it displayed also a highly synergistic profile when tested in combination with vemurafenib, thus proving its efficacy not only per se but even in a combination therapy, which is nowadays acknowledged as the cornerstone approach of the forthcoming tumour management.

Product Details of 64-10-8. About 1-Phenylurea, If you have any questions, you can contact Quattrini, L; Coviello, V; Sartini, S; Di Desidero, T; Orlandi, P; Ke, YY; Liu, KL; Hsieh, HP; Bocci, G; La Motta, C or concate me.

Reference:
Thiomorpholine – Wikipedia,
,Thiomorpholine | C4H9NS – PubChem

An article Evaluation of a series of phenyl-type stationary phases in supercritical fluid chromatography with the linear solvation energy relationship model and its application to the separation of phenolic compounds WOS:000518869100030 published article about LIQUID-CHROMATOGRAPHY; CLASSIFICATION; PURIFICATION; SELECTIVITY; RETENTION; SYSTEM; SFC in [Jiang, Dasen; Ke, Yanxiong; Cai, Jianfeng; Zhang, Huanhuan; Fu, Qing; Jin, Yu; Liang, Xinmiao] East China Univ Sci & Technol, Engn Res Ctr Pharmaceut Proc Chem, Sch Pharm, Minist Educ, Shanghai 200237, Peoples R China; [Liang, Xinmiao] Chinese Acad Sci, Dalian Inst Chem Phys, Key Lab Separat Sci Analyt Chem, Key Lab Nat Med, Dalian 116023, Liaoning, Peoples R China in 2020.0, Cited 29.0. Application In Synthesis of 1-Phenylurea. The Name is 1-Phenylurea. Through research, I have a further understanding and discovery of 64-10-8

In recent years, supercritical fluid chromatography (SFC) has become a powerful tool in modern analytical chemistry, and the diversity of stationary phases in SFC promotes phenyl-type phases to confront with a significant resurgence of interest. In this paper, a series of phenyl-type stationary phases with different substituted benzenes involving N-propylbenzamide (PB), 4-fluoro-N-propylbenzamide (PB-F), and 4-ethyl-N-propylbenzamide (PB-ET) were synthesized. Retention mechanism of these phases in SFC was investigated using a linear solvation energy relationship (LSER) model. The phenyl-type stationary phases with all positive parameters can provide all types of interaction, typically involving hydrogen bonding, dipole-dipole and dispersive interactions. The different benzene’s substituents of the stationary phases mainly affected their hydrogen bonding and dipole-dipole interactions, which could be reflected by the angle between the solvation vectors to some extent. The k-k plot showed that the selectivity difference of phenyl-type stationary phases was closely related to the type of solute. Thus, based on twenty-five natural phenolic compounds, two systems with high orthogonality (63.49%) were constructed using three columns, namely phenyl column (PHE) x PB-F and PB x PB-F. Finally, after investigating the influence of chromatographic conditions, ten flavonoids could be separated by using PB, PB-F and PHE columns in SFC. (C) 2019 Published by Elsevier B.V.

About 1-Phenylurea, If you have any questions, you can contact Jiang, DS; Ke, YX; Cai, JF; Zhang, HH; Fu, Q; Jin, Y; Liang, XM or concate me.. Application In Synthesis of 1-Phenylurea

Reference:
Thiomorpholine – Wikipedia,
,Thiomorpholine | C4H9NS – PubChem

Product Details of 64-10-8. In 2020.0 DIABETES CARE published article about TYPE-2 DIABETES-MELLITUS; ADD-ON THERAPY; SGLT2 INHIBITORS; TOLERABILITY; METFORMIN in [Jabbour, Serge A.] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Frias, Juan P.] Natl Res Inst, Los Angeles, CA USA; [Ahmed, Azazuddin] Apex Med Res, Chicago, IL USA; [Hardy, Elise] AstraZeneca, Gaithersburg, MD USA; [Choi, Jasmine] Statum Res, Irvine, CA USA; [Sjostrom, C. David] AstraZeneca, Gothenburg, Sweden; [Guja, Cristian] Carol Davila Univ Med & Pharm, Bucharest, Romania in 2020.0, Cited 17.0. The Name is 1-Phenylurea. Through research, I have a further understanding and discovery of 64-10-8.

OBJECTIVE In patients with type 2 diabetes uncontrolled with metformin, exenatide once weekly (QW) plus dapagliflozin produced greater reductions in glycemic parameters (glycated hemoglobin [HbA(1c)], fasting plasma glucose [FPG], and 2-h postprandial glucose [2-h PPG]), weight, and systolic blood pressure (SBP) than exenatide QW or dapagliflozin alone after 28 weeks of treatment in DURATION-8. Following a 24-week extension period, improvements were sustained at 52 weeks. In this study, we investigated efficacy and safety at 104 weeks after randomization. RESEARCH DESIGN AND METHODS DURATION-8 was a 104-week, multicenter, double-blind, randomized, active-controlled, phase 3 trial. In total, 695 adults (aged >= 18 years) with type 2 diabetes and inadequate glycemic control (HbA(1c)8.0-12.0% [64-108 mmol/mol]) despite stable metformin monotherapy (>= 1,500 mg/day) were randomly assigned (1:1:1) to receive exenatide 2 mg QW plus once-daily dapagliflozin 10 mg, exenatide QW plus placebo, or dapagliflozin plus placebo. All 104-week evaluations were exploratory. RESULTS At week 104, 431 (62.0%) patients completed treatment. The adjusted least squares mean change (SE) from baseline to week 104 in HbA(1c)was greater with exenatide QW plus dapagliflozin (-1.70% [0.11]) versus exenatide QW plus placebo (-1.29% [0.12];P= 0.007) and dapagliflozin plus placebo (-1.06% [0.12];P< 0.001). Clinically relevant changes in FPG, 2-h PPG, weight, and SBP were also observed with exenatide QW plus dapagliflozin. There were no unexpected safety findings, and exenatide QW plus dapagliflozin was well tolerated, with no episodes of major hypoglycemia. CONCLUSIONS In this exploratory analysis, among those individuals who completed the trial without rescue therapy, there was clinically relevant efficacy over 2 years with exenatide QW plus dapagliflozin, with no unexpected safety findings. Product Details of 64-10-8. About 1-Phenylurea, If you have any questions, you can contact Jabbour, SA; Frias, JP; Ahmed, A; Hardy, E; Choi, J; Sjostrom, CD; Guja, C or concate me.

Reference:
Thiomorpholine – Wikipedia,
,Thiomorpholine | C4H9NS – PubChem